Goga Bitadze
26-27 Projection
FG%: league rank #16, top 20 in the league.
ORL
Value
+0.31
League Leader3.1
This Player1
League Average0.5
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 19-20 | n/a |
| 20-21 | #269 |
| 21-22 | #288 |
| 22-23 | #304 |
| 23-24 | #211 |
| 24-25 | #136 |
| 25-26 | #203 |
| 26-27 Projection | #208 |
Stat Trend
Track role, durability, and category growth by season.
Full data
| Season | PTS |
|---|---|
| 19-20 | 3.2 |
| 20-21 | 5.1 |
| 21-22 | 7 |
| 22-23 | 4.4 |
| 23-24 | 5 |
| 24-25 | 7.2 |
| 25-26 | 5.9 |
| 26-27 Projection | 5.3 |
Within-Season Trend
PTS by month across 25-26 (averages). Useful for spotting injury recovery and rookie/second-year ramps. Change the stat with the selector above.
Fantasy playoffs (final ~3 weeks)NBA playoffs (aggregate — not in averages or ranks)
Full data
| Month | PTS |
|---|---|
| Oct 2025 | 5.8 |
| Nov 2025 | 6.5 |
| Dec 2025 | 5.6 |
| Jan 2026 | 5.5 |
| Feb 2026 | 4.7 |
| Mar 2026 | 5 |
| Apr 2026 | 7.9 |
| Playoffs (playoffs) | 2.8 |
Fantasy playoffs run the final ~3 weeks of the season (late March into April); shown approximately at month resolution and dependent on your league's settings. ESPN and Yahoo defaults differ by about a week.
Depth Chart
Depth Chart
ORL — all five positions, best player first at each spot.
Season History
Compare season stats and fantasy ranks for draft analysis.
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-27 ProjectionModel Zero | 27 | ORL | 63 | 0 | 15 | #208 | 0.31 | 5.3 | 4.7 | 1.2 | 0.6 | 1.1 | 0 | 64.9% | 3.5 | 68.4% | 1.4 | 0.6 |
| 25-26 | 26 | ORL | 64 | 0 | 15.2 | #203 | -0.04 | 5.9 | 5 | 1.3 | 0.6 | 1 | 0 | 67.6% | 3.5 | 71.1% | 1.5 | 0.7 |
| 24-25 | 25 | ORL | 70 | 0 | 20.4 | #136 | 1.28 | 7.2 | 6.6 | 2 | 0.7 | 1.4 | 0 | 61.1% | 4.8 | 63.9% | 1.9 | 1 |
| 23-24 | 24 | ORL | 62 | 0 | 15.4 | #211 | -0.81 | 5 | 4.6 | 1.3 | 0.5 | 1.2 | 0 | 60.3% | 3.4 | 65.5% | 1.4 | 0.7 |
| 22-23 | 23 | ORL | 38 | 0 | 12 | #304 | -2.87 | 4.4 | 3.6 | 1 | 0.4 | 0.7 | 0.2 | 55.2% | 3.3 | 54.8% | 1.1 | 0.6 |
| 21-22 | 22 | IND | 50 | 0 | 14.6 | #288 | -1.98 | 7 | 3.5 | 1.1 | 0.4 | 0.8 | 0.5 | 52.0% | 5 | 68.1% | 1.9 | 0.9 |
| 20-21 | 21 | IND | 45 | 0 | 12.5 | #269 | -2.05 | 5.1 | 3.3 | 0.8 | 0.2 | 1.3 | 0.4 | 42.8% | 4.3 | 73.8% | 1.4 | 0.4 |
| 19-20 | 20 | IND | 54 | 0 | 8.7 | n/a | n/a | 3.2 | 2 | 0.4 | 0.2 | 0.7 | 0.1 | 46.7% | 2.8 | 72.7% | 0.6 | 0.5 |